Target intelligence / Profile preview

Plasma cytokines, endotoxins, and circulating plasma proteins

Molecular classification
Cytokine, Lipopolysaccharide, Plasma protein, Acute-phase reactant
01

Overview

Plasma cytokines, endotoxins, and circulating plasma proteins represent a heterogeneous group of blood-borne molecules that serve as critical mediators of the systemic immune response and physiological homeostasis. Cytokines, including interleukins and tumor necrosis factors, are small signaling proteins that coordinate cellular responses to infection and injury (Source: Dinarello, C. A., Blood, 2011). Endotoxins, primarily lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria, are potent pro-inflammatory triggers that can induce life-threatening conditions such as septic shock (Source: Opal, S. M., et al., Journal of Infectious Diseases, 2010). Circulating plasma proteins encompass a wide range of molecules, including acute-phase reactants like C-reactive protein and transport proteins like albumin, which are often dysregulated during systemic illness. Therapeutic intervention targeting these mediators is a cornerstone of treating inflammatory and infectious diseases, utilizing either targeted biologics to neutralize specific cytokines or extracorporeal blood purification devices to broadly reduce the circulating peak of inflammatory markers (Source: Monard, C., et al., Critical Care, 2023). These approaches aim to restore immunological balance and prevent organ dysfunction in critically ill patients.

Other names
Circulating inflammatory mediatorsPlasma inflammatory markersBlood-borne mediatorsHumoral mediators of inflammation
02

Mechanism of action

Mechanisms include the direct neutralization of circulating ligands by monoclonal antibodies, competitive inhibition of cell-surface receptors, or the physical removal of these substances from the blood via extracorporeal adsorption and filtration (Source: Ronco, C., et al., Nature Reviews Nephrology, 2017).

03

Biological functions

Immune responseSignal transductionInflammationHomeostasisCoagulation
04

Disease associations

SepsisSystemic Inflammatory Response SyndromeCytokine release syndromeAutoimmune diseaseSeptic shock
05

Safety considerations

Increased risk of opportunistic infectionsSystemic immunosuppression (Source: Cohen, J., Nature, 2002)Non-specific removal of therapeutic drugs or nutrients during hemoperfusionHypersensitivity reactions to biological agents
06

Interacting drugs

Infliximab

7 more in the full profile.

07

Biomarkers

C-reactive proteinProcalcitoninInterleukin-6Tumor necrosis factor-alphaLactate

Beyond the preview

Go deeper on Plasma cytokines, endotoxins, and circulating plasma proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma cytokines, endotoxins, and circulating plasma proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call